These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21222176)

  • 1. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
    Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
    Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells.
    Qi Z; Xu X; Zhang B; Li Y; Liu J; Chen S; Chen G; Huo X
    Biochem Cell Biol; 2010 Aug; 88(4):697-704. PubMed ID: 20651842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
    Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
    Gu W; Payne E; Sun S; Burgess M; McMillan NA
    Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
    Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
    Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
    Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K; Lee AY; Kwon YK; Kwon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibiting effect of HPV16 E6 small interfering RNA on the growth of human cervical carcinoma xenotransplanted in nude mice].
    Guan LL; Peng ZL; Niu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):894-7. PubMed ID: 18478926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
    Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
    Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
    Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R; Krausz E; Helenius H; Hietanen S
    Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.